Outcome
    Moderate Evidence

    Quercetin for Histamine Balance

    Quercetin stabilizes mast cells and improved allergic rhinitis symptoms in small trials — the best-evidenced natural antihistamine supplement.

    Overview

    Quercetin is a flavonol found in onions, apples and capers, and its histamine claim rests on a well-characterised laboratory property: it stabilises mast cells so they release less histamine when triggered. In cell and animal work the effect is robust and dose dependent. Human evidence is thinner but no longer absent. The randomised placebo-controlled trial linked to this pairing found improved subjective nasal and ocular allergy symptom scores with repeated oral intake of a quercetin-containing supplement. The persistent problem is bioavailability: plain quercetin aglycone is poorly absorbed, so the concentrations that stabilise mast cells in a dish are difficult to reach in tissue with a capsule.

    Verdict

    Likely effective

    Strong mechanistic evidence for mast cell stabilisation and a randomised trial reporting improved allergy symptom scores. Human data remain limited and bioavailability is the main constraint on translating laboratory effects into clinical ones.

    Prevention, not rescue

    Mast cell stabilisation works before degranulation. Quercetin will not stop a reaction that has already started, which is what antihistamines are for.

    How It Works

    Quercetin inhibits the calcium influx and the phospholipase A2 signalling that mast cells and basophils require to degranulate after IgE cross-linking. Less degranulation means less preformed histamine, tryptase and heparin released into tissue, which is a different point of action from H1 antihistamines that block the receptor after histamine is already out. There are secondary contributions. Quercetin reduces synthesis of leukotrienes and prostaglandins through the arachidonic acid cascade, which addresses the delayed phase of an allergic response that antihistamines handle poorly, and it inhibits NF-kappaB driven transcription of inflammatory cytokines. Weak inhibition of diamine oxidase has been described in vitro, which is why people with histamine intolerance are occasionally advised to introduce quercetin carefully.

    Pathways involved

    Mast cell membrane stabilisation
    Reduced calcium influx on IgE crosslinking
    Lower leukotriene and prostaglandin synthesis
    NF-kappaB inhibition
    Antioxidant activity in mucosal tissue

    Dosing & Protocol

    ScenarioDoseFormTiming
    Standard allergy dosing500 mg twice dailyQuercetin dihydrateBetween meals
    Enhanced absorption250 mg twice dailyPhytosome or EMIQWith a fat-containing meal
    Seasonal pre-loading500 to 1000 mg dailyAnyStart 4 to 6 weeks before season
    Upper end used in trials1000 mg dailyQuercetin dihydrateDivided
    1. 1

      Start before the season, not during it· Weeks minus 6 to 0

      Mast cell stabilisation is preventive. Beginning four to six weeks before your usual trigger period is how it is meant to be used.

    2. 2

      Take 500 mg twice daily· Ongoing

      Divided dosing suits the short half-life of quercetin better than a single large dose.

    3. 3

      Consider an enhanced-absorption form· From the start

      Phytosome and enzymatically modified isoquercitrin forms reach several times the plasma concentration of plain aglycone at the same dose.

    4. 4

      Keep your antihistamine available· Throughout

      Quercetin is an adjunct. Do not stop a working antihistamine in order to test it.

    5. 5

      Score symptoms daily during the season· Season

      A simple daily nasal and ocular score, compared against last season, is the only practical way to judge it.

    Bioavailability is the whole difficulty

    Plain quercetin aglycone has low and variable oral absorption. Much of the disappointment with quercetin in practice is a delivery problem rather than a mechanism problem.

    Bromelain and vitamin C are commonly combined with quercetin in commercial allergy formulas. Bromelain is included on the reasonable grounds that it aids absorption of flavonoids, and vitamin C on the basis that it supports histamine breakdown, but neither combination has been isolated and tested properly in humans.

    Evidence

    The linked randomised, placebo-controlled, double-blind parallel-group trial gave repeated oral doses of a quercetin-containing supplement and measured allergic symptoms. Participants reported improved subjective ocular and nasal symptom scores relative to placebo, which is a genuine human result in the right direction. Interpretation needs care. The tested product was a quercetin-containing supplement rather than isolated quercetin, endpoints were subjective symptom scores rather than objective measures such as nasal airflow or serum tryptase, and the wider evidence base is dominated by in vitro and animal studies where concentrations far exceed anything achievable orally. This is enough to justify a trial in a person with seasonal symptoms and not enough to position quercetin as an alternative to established antihistamine therapy.

    Studies linked to this pairing.

    Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: a randomized, placebo-controlled, double-blind parallel-group trial

    Score: 6/10
    2022
    rct

    Kawai M, Hirano T

    Repeated oral quercetin intake improved subjective ocular and nasal allergy symptom scores versus placebo

    View source
    Best linked evidence
    Randomised, double-blind, placebo-controlled parallel-group trial
    Linked result
    Improved subjective nasal and ocular allergy symptom scores
    Studied dose
    500 to 1000 mg daily, divided
    Main limitation
    Subjective endpoints and low oral bioavailability
    Certainty
    Low to moderate for symptoms; strong for the underlying mechanism

    Safety

    Short-term quercetin at up to 1000 mg daily is well tolerated, with headache and mild stomach upset the usual complaints. Long-term safety above that dose is not established, and there is a specific caution at high intravenous doses that does not apply to oral use. Two practical points deserve attention. Quercetin can inhibit renal drug transport, so it should be avoided in significant kidney impairment without advice, and there is a theoretical concern about mutagenicity from very old in vitro work that has not been reproduced in humans consuming dietary or supplemental amounts. Most importantly, anaphylaxis is not a condition to manage with a flavonoid: anyone with severe allergy needs adrenaline and a clinician.

    Never substitute quercetin for emergency allergy treatment

    If you have been prescribed an adrenaline autoinjector, carry and use it. Quercetin has no role in an acute severe reaction.

    Reported effects

    Headache
    Tingling in extremities at high doses
    Mild stomach upset
    Caution in kidney impairment
    Long-term high-dose safety unknown

    Interactions & Conflicts

    Quercetin is a meaningful cytochrome P450 inhibitor, which puts it in a different interaction class from most flavonoids. It affects CYP3A4 and CYP2C8 and inhibits P-glycoprotein, so it can raise levels of drugs with a narrow therapeutic margin.
    Interacts withSeverityMechanismAction
    Ciclosporin and tacrolimus
    high
    		CYP3A4 and P-glycoprotein inhibition raises drug levelsAvoid unless levels are being monitored
    Warfarin
    moderate
    		Altered metabolism plus mild antiplatelet activityMonitor INR closely if used
    Fluoroquinolone antibiotics
    moderate
    		Competition at bacterial DNA gyrase has been suggested in vitroSeparate use during a course
    Chemotherapy agents
    high
    		CYP mediated changes in drug exposureOnly with oncology approval
    Antihypertensives
    low
    		Quercetin has a mild blood pressure lowering effectMonitor blood pressure early on

    References

    1. Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: a randomized, placebo-controlled, double-blind parallel-group trial. Eur Rev Med Pharmacol Sci. 2022
    2. Mlcek J et al. Quercetin and its anti-allergic immune response. Molecules. 2016

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.